HighVista Strategies’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-66,526
| Closed | -$468K | – | 150 |
|
|
2023
Q2 | $468K | Buy |
+66,526
| New | +$468K | 0.21% | 120 |
|
|
2022
Q4 | – | Sell |
-72,104
| Closed | -$691K | – | 114 |
|
|
2022
Q3 | $691K | Buy |
72,104
+27,142
| +60% | +$260K | 0.39% | 70 |
|
|
2022
Q2 | $496K | Sell |
44,962
-9,439
| -17% | -$104K | 0.3% | 76 |
|
|
2022
Q1 | $906K | Sell |
54,401
-12,238
| -18% | -$204K | 0.58% | 44 |
|
|
2021
Q4 | $1.27M | Buy |
66,639
+10,363
| +18% | +$198K | 1.01% | 31 |
|
|
2021
Q3 | $1.39M | Buy |
56,276
+23,818
| +73% | +$587K | 0.92% | 23 |
|
|
2021
Q2 | $845K | Buy |
32,458
+14,295
| +79% | +$372K | 0.6% | 35 |
|
|
2021
Q1 | $575K | Sell |
18,163
-2,260
| -11% | -$71.5K | 0.43% | 63 |
|
|
2020
Q4 | $948K | Buy |
20,423
+3,599
| +21% | +$167K | 0.61% | 31 |
|
|
2020
Q3 | $554K | Buy |
16,824
+1,343
| +9% | +$44.2K | 0.4% | 38 |
|
|
2020
Q2 | $425K | Buy |
+15,481
| New | +$425K | 0.35% | 45 |
|